Evogene Ltd logo

Evogene Ltd share price today

(EVGN)

Evogene Ltd share price is $1.43 & ₹121.10 as on 6 Dec 2024, 10.30 hrs IST

$1.43

-0.01

(-0.69%)

Market is closed - opens 8 PM, 09 Dec 2024

View live Evogene Ltd share price in Dollar and Rupees. Guide to invest in Evogene Ltd from India. Also see the sentimental analysis on Indian investors investing in Evogene Ltd. Get details on the Indian mutual funds that are investing in Evogene Ltd. Get Analyst recommendations and forecasts along with all the Evogene Ltd's financials.

Evogene Ltd share price movements

  • $1.40
    $1.47

    Day's Volatility :4.92%

  • $1.42
    $10.40

    52 Weeks Volatility :86.38%

Evogene Ltd Returns

PeriodEvogene LtdIndex (Russel 2000)
3 Months
-51.84%
0.0%
6 Months
-78.57%
0.0%
1 Year
-80.01%
0.0%
3 Years
-92.73%
-20.3%

Evogene Ltd Key Statistics

in dollars & INR

Previous Close
$1.44
Open
$1.4725
Today's High
$1.46
Today's Low
$1.43
Market Capitalization
$10.0M
Today's Volume
$34.6K
52 Week High
$10.4
52 Week Low
$1.4
Revenue TTM
$9.4M
EBITDA
$-19.7M
Earnings Per Share (EPS)
$-4.28
Profit Margin
-210.26%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-82.37%

How to invest in Evogene Ltd from India?

It is very easy for Indian residents to invest directly in Evogene Ltd from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Evogene Ltd stock in both rupees (INR) and dollars (USD). Search for Evogene Ltd or EVGN on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Evogene Ltd or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Evogene Ltd shares which would translate to 0.592 fractional shares of Evogene Ltd as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Evogene Ltd

3%

Period: Sep 9, 2024 to Dec 8, 2024. Change in 30 Days versus previous period

Search volume for Evogene Ltd on INDmoney from India has grown in the last 30 days as on Dec 9, 2024. 3% more investors are searching Evogene Ltd in the last 30 days versus the previous period.

Global Institutional Holdings in Evogene Ltd

  • SILVERARC CAPITAL MANAGEMENT, LLC

    4.53%

  • Armistice Capital, LLC

    2.87%

  • Morgan Stanley - Brokerage Accounts

    0.19%

  • BNP Paribas Arbitrage, SA

    0.18%

  • Renaissance Investment Group, LLC

    0.15%

  • UBS Group AG

    0.13%

Analyst Recommendation on Evogene Ltd

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 8 Wall street analysts offering stock ratings for Evogene Ltd(by analysts ranked 0 to 5 stars)

Based on 8 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
7
7
8
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Evogene Ltd

What analysts predicted

Upside of 468.18%

Current:

$1.43

Target:

$8.13

Insights on Evogene Ltd

  • Price Movement

    In the last 7 days, EVGN stock has moved down by -10.0%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 914.0K → 1.79M (in $), with an average increase of 49.1% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 3 quarters, -3.86M → -7.63M (in $), with an average decrease of 40.5% per quarter
  • EVGN vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 48.1% return, outperforming this stock by 130.2%
  • EVGN vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 46.0% return, outperforming this stock by 139.1%
  • Price to Sales

    ForEVGN every $1 of sales, investors are willing to pay $0.8, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $15.5 for every $1 of sales.

Evogene Ltd Technicals Summary

Sell

Neutral

Buy

Evogene Ltd is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Evogene Ltd Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Evogene Ltd
-26.15%
-78.57%
-80.01%
-92.73%
-89.09%
Regeneron Pharmaceuticals, Inc.
-7.0%
-23.34%
-9.49%
14.69%
105.58%
Biontech Se
9.3%
21.29%
18.26%
-53.88%
279.68%
Alnylam Pharmaceuticals, Inc.
-10.01%
64.08%
47.33%
45.01%
111.98%
Vertex Pharmaceuticals Incorporated
-8.33%
-4.83%
29.09%
121.05%
109.05%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Evogene Ltd
0.3
NA
0.0
-4.11
-0.82
-0.28
NA
2.38
Regeneron Pharmaceuticals, Inc.
18.56
18.56
1.12
44.92
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.06
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.21
0.54
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Evogene Ltd
Buy
$10.0M
-89.09%
0.3
-210.26%
Regeneron Pharmaceuticals, Inc.
Buy
$82.9B
105.58%
18.56
33.61%
Biontech Se
Buy
$28.5B
279.68%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$32.7B
111.98%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$118.4B
109.05%
32.84
-4.51%

About Evogene Ltd

evogene is a plant genomics company, utilizing a proprietary integrated technology infrastructure to enhance seed traits underlying crop productivity. evogene offers a complete solution for crop productivity improvement through biotechnology and advanced breeding using a unique technology infrastructure that is based on deep scientific understandings of plant genomics and proprietary computational capabilities. the company has strategic collaborations with world-leading agricultural companies to develop improved seed traits in relation to yield and a-biotic stress (such as tolerance to drought), and biotic stress (such as resistance to disease), in key crops as corn, soybean, wheat and rice. in addition, evogene has earlier stage operations in agriculture chemicals, and seeds focusing on second generation feedstock for biodiesel. the company's headquarters are located in rehovot, israel and is listed for trading on the tel aviv stock exchange (tase: evgn) and on the new york stock exch
Organization
Evogene Ltd
Employees
142
CEO
Mr. Ofer Haviv CPA
Industry
Health Technology

Management People of Evogene Ltd

NameTitle
Mr. Ofer Haviv CPA
CEO & President
Dr. Brian Ember
Chief Executive Officer of AgPlenus Ltd
Dr. Elran Hillel Haber M.B.A., Ph.D.
Chief Executive Officer of Biomica Ltd
Mr. Amit Noam Capt. res.
Chief Executive Officer of Lavie Bio Ltd.
Mr. Yaron Eldad
Chief Financial Officer
Rachel Pomerantz Gerber
Head of Investor Relations
Mr. Sassi Masliah
Vice President of Corporate Development
Ms. Liat Foigel Wejgman
Vice President of Human Resources
Mr. Eyal Ronen
Executive Vice President of Business Development
Mr. Yoash Zohar
Chief Executive Officer of Casterra Ag Ltd.

Important FAQs about investing in Evogene Ltd from India :

What is Evogene Ltd share price today?

Evogene Ltd (EVGN) share price today is $1.43.

Can Indians buy Evogene Ltd shares?

Yes, Indians can invest in the Evogene Ltd (EVGN) from India.

With INDmoney, you can buy Evogene Ltd at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Evogene Ltd at zero transaction cost.

How can I buy Evogene Ltd shares from India?

It is very easy to buy Evogene Ltd from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Evogene Ltd be purchased?

Yes, you can buy fractional shares of Evogene Ltd with INDmoney app.

What are the documents required to start investing in Evogene Ltd stocks?

To start investing in Evogene Ltd, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Evogene Ltd

Today’s highest price of Evogene Ltd (EVGN) is $1.47.

Today’s lowest price of Evogene Ltd (EVGN) is $1.40.

What is today's market capitalisation of Evogene Ltd

Today's market capitalisation of Evogene Ltd EVGN is 10.0M

What is the 52 Week High and Low Range of Evogene Ltd

  • 52 Week High

    $10.40

  • 52 Week Low

    $1.42

How much percentage Evogene Ltd is down from its 52 Week High?

Evogene Ltd (EVGN) share price is $1.43. It is down by 86.25% from its 52 Week High price of $10.40.

How much percentage Evogene Ltd is up from its 52 Week low?

Evogene Ltd (EVGN) share price is $1.43. It is up by 0.99% from its 52 Week Low price of $1.42.

What are the historical returns of Evogene Ltd?

  • 1 Month Returns

    -26.15%

  • 3 Months Returns

    -78.57%

  • 1 Year Returns

    -80.01%

  • 5 Years Returns

    -89.09%

Who is the Chief Executive Officer (CEO) of Evogene Ltd

Mr. Ofer Haviv CPA is the current Chief Executive Officer (CEO) of Evogene Ltd.